BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

计划入组 150 人 · 首次发布于 2019 年 3 月 5 日

Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification

计划入组 201 人 · 首次发布于 2013 年 4 月 1 日

BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle Prominence

计划入组 377 人 · 首次发布于 2019 年 8 月 29 日

autologous muscle precursor cells

Common Muscle Disorder(miRecule)

mRNA vaccine (muscle spasm)

CATALO NATURALS (AUSTRALIA) PTY LTD

Australia

BioNTech SE

Germany

Cytokinetics, Incorporated

United States

BOTOX® Cosmetic Approved in China for Masseter Muscle Prominence

Asciminib's Rising Prominence and Evolving Treatment Strategies in Chronic Myeloid Leukemia

Actimed Therapeutics Advances Novel Muscle-Preserving Therapies for Cancer Cachexia and GLP-1 Associated Muscle Loss